Company Description
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical ...
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
Valuation
P/E Current
30.84
P/E Ratio (with extraordinary items)
25.97
P/E Ratio (without extraordinary items)
25.81
Price to Sales Ratio
2.36
Price to Book Ratio
1.16
Price to Cash Flow Ratio
23.83
Enterprise Value to EBITDA
13.22
Enterprise Value to Sales
1.61
Total Debt to Enterprise Value
0.01
Efficiency
Revenue/Employee
46,345,251.00
Income Per Employee
4,240,881.00
Receivables Turnover
3.30
Total Asset Turnover
0.42
Liquidity
Current Ratio
4.68
Quick Ratio
4.23
Cash Ratio
3.21
Profitability
Gross Margin
56.65
Operating Margin
9.04
Pretax Margin
12.56
Net Margin
9.15
Return on Assets
3.81
Return on Equity
4.61
Return on Total Capital
4.48
Return on Invested Capital
4.59
Capital Structure
Total Debt to Total Equity
0.90
Total Debt to Total Capital
0.89
Total Debt to Total Assets
0.73
Long-Term Debt to Equity
0.35
Long-Term Debt to Total Capital
0.35
Officers and Executives
| Name | Age | Officer Since | Title |
|---|---|---|---|
| Mr. Hirotaka Nakatomi | 82 | 1966 | Chairman |
| Mr. Kazuhide Nakatomi | 47 | 1999 | President & Representative Director |
| Mr. Shinichiro Takao | 65 | 1978 | Director, Executive Officer, Manager-Finance & IR |
| Mr. Takaaki Terahara | - | - | Senior Executive Officer, GM-R&D |
| Mr. Tetsuo Akiyama | 68 | 1974 | MD, Executive Officer & Head-Operations |
Insider Actions
MarketWatch News on HPX
No News currently available for HPX
Other News on HPX
No News currently available for HPX
